Authors: Boyd, RA Stern, RH Stewart, BH Wu, XC Reyner, EL Zegarac, EA Randinitis, EJ Whitfield, L

Citation: Ra. Boyd et al., Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion, J CLIN PHAR, 40(1), 2000, pp. 91-98

Authors: Smaill, JB Rewcastle, GW Loo, JA Greis, KD Chan, OH Reyner, EL Lipka, E Showalter, HDH Vincent, PW Elliott, WL Denny, WA

Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions, J MED CHEM, 43(7), 2000, pp. 1380-1397

Authors: Smaill, JB Rewcastle, GW Bridges, AJ Zhou, HR Showalter, HDH Fry, DW Nelson, JM Sherwood, V Elliott, WL Vincent, PW DeJohn, DE Loo, JA Greis, KD Chan, OH Reyner, EL Lipka, E Denny, WA

Citation: Jb. Smaill et al., Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]-pyrimidine-6-acrylamides bearing additional solubilizing functions(vol 43, pg 1380, 2000), J MED CHEM, 43(16), 2000, pp. 3199-3199